Currently, Encompass Health Corp [EHC] is trading at $117.58, up 0.92%. An important factor to consider is whether the stock is rising or falling in short-term value. The EHC shares have gain 8.34% over the last week, with a monthly amount glided 0.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Encompass Health Corp [NYSE: EHC] stock has seen the most recent analyst activity on October 11, 2024, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $115. Previously, Leerink Partners started tracking the stock with Outperform rating on July 10, 2024, and set its price target to $100. On March 06, 2024, Barclays initiated with a Overweight rating and assigned a price target of $95 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $57 on March 14, 2023. UBS initiated its recommendation with a Buy and recommended $98 as its price target on September 24, 2021. Raymond James upgraded its rating to Strong Buy for this stock on August 02, 2021, and upped its price target to $107. In a note dated November 23, 2020, Barclays upgraded an Overweight rating on this stock but restated the target price of $96.
This stock has fluctuated between a low of $85.21 and a high of $123.13 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $125 within the next 12 months. Encompass Health Corp [NYSE: EHC] shares were valued at $117.58 at the most recent close of the market. An investor can expect a potential return of 6.31% based on the average EHC price forecast.
Analyzing the EHC fundamentals
Trailing Twelve Months sales for Encompass Health Corp [NYSE:EHC] were 5.67B which represents 12.03% growth. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.23 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Encompass Health Corp [NYSE:EHC] is 1.06. On the other hand, the Quick Ratio is 1.06, and the Cash Ratio is 0.11. Considering the valuation of this stock, the price to sales ratio is 2.09, the price to book ratio is 5.20 and price to earnings (TTM) ratio is 22.99.
Transactions by insiders
Recent insider trading involved Tarr Mark J, President & CEO, that happened on May 20 ’25 when 0.12 million shares were sold. Officer, Mark Tarr completed a deal on May 20 ’25 to buy 0.12 million shares. Meanwhile, Chief Medical Officer Charbonneau Elissa Joy sold 4279.0 shares on May 06 ’25.
